Patients Coming Off Weight-Loss Jabs Regain Weight Four Times Faster Than People Using Diet and Exercise

New research suggests that people who come off new GLP-1 drugs like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who end conventional diet and exercise plans.

Published data in a major health publication points out that while obese individuals can lose a large proportion of their body weight while on the medication, the weight is regained at an average rate of nearly a kilo each month once they quit.

"Individuals buying such medications must be cognizant of the potential of fast weight regain when the treatment ends," cautioned researcher Dr. Susan Jebb.

Such speed of regain suggests a return to starting mass within about one and a half years.

Analyzing Treatments

The analysis, which reviewed dozens of trials involving thousands of patients, compared the outcomes of these new drugs with conventional dieting.

Researchers emphasize that people who lose weight through diet and exercise typically experience a slower weight regain—approximately 0.1 kg a month—after stopping.

The Reason for the Fast Rebound

Experts suggest the mode of action of the jabs is key to understanding the accelerated weight return.

GLP-1 drugs imitate a natural hormone called GLP-1, which helps regulate hunger.

"Artificially providing GLP-1 concentrations several times higher than normal might result in the body to produce less of its own natural GLP-1, and could reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this hormone supplement results in hunger is uncontrolled, making overeating far more likely."

A Chronic Condition?

Health authorities suggest the injections for individuals with obesity-related health risks, alongside prescribed lifestyle changes.

Many experts contend that, considering the likelihood of weight regain, the therapy might need to be ongoing.

This perspective is echoed by pharmaceutical companies, who state that the results "emphasize the chronic nature of obesity," akin to managing conditions like hypertension.

User Experiences

Individuals who have stopped the jabs explain a intense resurgence of appetite.

"It felt as if a switch that goes on and you're instantly starving," said an individual.

This challenge is worsened if individuals have not established permanent dietary or behavioural modifications during therapy.

Growing Adoption

Survey data indicate that millions of adults in the UK have used these injections in the last 12 months, with interest continuing to grow.

• Adoption is higher among females compared to males.
• The middle-aged demographic shows the greatest usage rates.
• Many obtain the medications through private prescriptions rather than the NHS.

Finally, clinicians emphasize that while the jabs are effective tools for weight loss, they are not a standalone solution and lasting health benefits likely depends on combined lifestyle management.